Summary
| Direction in Low Back Pain | ↑ Elevated — higher than in the comparison group |
|---|---|
| Category | Inflammatory |
| Compared against | chronic nonspecific LBP vs asymptomatic controls |
| Test type | Blood test (serum / plasma / whole blood) |
| LOINC code | 26881-3 |
| Source | Injeyan et al. 2025 — doi:10.1177/11772719251355038 |
| Condition atlas | Low Back Pain Biomarker Atlas |
Other conditions where Interleukin-6 (IL-6) is reported
| Atlas entry | Direction | Compared against |
|---|---|---|
| Interleukin-6 in Atrial Fibrillation | ↕ inconsistent | vs AF patients vs. implied healthy/reference |
| Interleukin-6 in Epilepsy | ↑ elevated | vs not explicitly named (comparison implied by disease state vs. normal/control) |
| Interleukin-6 (IL-6) in Gulf War Illness | ↑ elevated | vs HGV |
| Interleukin-6 (IL-6) in Long COVID | ↑ elevated | vs HC, R |
| Interleukin-6 (IL-6) in Lyme Disease | ↑ elevated | vs HC |
| IL-6 in Major Depressive Disorder | ↑ elevated | vs females with depression vs healthy female controls |
| Interleukin-6 (IL-6) in ME/CFS | ↕ inconsistent | vs HC |
| Interleukin-6 in Migraine | ↑ elevated | vs headache-free controls |
| IL-6 in PACVS | ↑ elevated | vs HC |
| IL-6 in Rheumatoid Arthritis | ↑ elevated | vs RA vs healthy (established inflammatory pathway/drug target) |
See the cross-condition hub: Interleukin-6 (IL-6) across conditions.
Related Inflammatory markers in Low Back Pain
Full list: Low Back Pain Biomarker Atlas.
Frequently asked questions
Is IL-6 high or low in Low Back Pain?
Elevated. Studies summarised in the OSMF atlas report higher IL-6 in Low Back Pain than in the reference group of the cited comparison (chronic nonspecific LBP vs asymptomatic controls). Source: Injeyan et al. 2025.
Which test measures IL-6?
It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 26881-3. Many of the cited studies used research-grade assays, so clinical availability may vary.
Is one abnormal IL-6 result diagnostic of Low Back Pain?
No. No single biomarker is diagnostic of Low Back Pain. IL-6 findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.
Is IL-6 specific to Low Back Pain?
No. The same marker is also reported in Atrial Fibrillation, Epilepsy, Gulf War Illness, Long COVID, Lyme Disease, ME/CFS, Major Depressive Disorder, Migraine, PACVS, Rheumatoid Arthritis in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.
Cite this page
Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.